Higher expression levels of NQO1 mRNA were correlated with more advanced pathological stages in kidney renal papillary cell carcinoma and invasive breast carcinoma; In kidney chromophobe, kidney renal clear cell carcinoma, and pan-kidney cohort, NQO1 mRNA levels are lowest at SatgeII. This evidence concerns the gene NQO1 and urogenital neoplasm.